Earnings History Data for Neurogene Inc. (NGNE) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Neurogene Inc.
Neurogene Inc. is a clinical-stage company which bring life-changing genetic medicines to patients and families affected by rare neurological diseases. Neurogene Inc., formerly known as Neoleukin Therapeutics Inc., is based in NEW YORK.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 09-08-2024 | PM | NGNE | Neurogene Inc. | 491.56 | -1.09 | -1.02 | -0.80 | Neoleukin Therapeutics GAAP EPS of -$1.09 misses by $0.07, revenue of $0.93M [8/9/2024 7:46 AM] |
35.66 | -0.89 (-2.44%) |
36.55 | 0.0 (0.00%) |
12.20 - 53.00 | 100,465 | 120,000 | 1,428 | ||
| 10-05-2024 | PM | NGNE | NEUROGENE INC | 423.00 | -1.00 | -1.03 | 0.00 | Neurogene GAAP EPS of -$1.00 beats by $0.03 [5/10/2024 7:46 AM] |
32.41 | -0.80 (-2.41%) |
0.0 | 0.0 (0.00%) |
12.20 - 53.00 | 24,348 | 70,000 | 0 | ||
| 18-03-2024 | AH | NGNE | Neurogene Inc. | 352.70 | N/A | -1.30 | -4.80 | Neoleukin Therapeutics reports Q4 results [3/18/2024 4:42 PM] |
45.01 | 7.46 (19.85%) |
0.0 | 0.0 (0.00%) |
12.20 - 45.51 | 216,238 | 180,000 | 0 | ||